Sanofi (Nasdaq: SNY) deprioritized its mRNA flu shot effort. But it is still vigorously defending its substantial share of the flu vaccine market, with its egg-grown Fluzone products and egg-free ...

A century-old building that once served as Moderna's Cambridge headquarters could be reborn as affordable housing, under a ...

Merck and Moderna build a custom mRNA vaccine for each melanoma patient from tumor mutations. The strategy stumbles in cancers lacking enough targets ...

CI is pairing top AI and biotech minds on its board (plus an advisory role for OpenAI's Fidji Simo) as it tests models on a Novo Nordisk drug.

Moderna co-founder Bob Langer and AI pioneer Yann LeCun join Cellular Intelligence's board as the startup builds a foundation ...

One company is growing a commercial drug business with limited margin for error on the path to profitability. The other has a ...

Texas Instruments is capturing investor attention for its work in analog/mixed-signal semiconductors. Click to read more on ...

Doses of Moderna’s mFlusiva are available at CVS. Walgreens expects to begin receiving shipments of the vaccine any day now.

Moderna and Merck announced that their personalized mRNA cancer vaccine passed the Phase 3 test. Moderna and Merck reported ...

"As the conversation around AI grows darker, we risk becoming so consumed by what might go wrong that we stop paying ...

Oncology is not the only lever. The FDA cleared Moderna's flu shot mFLUSIVA on August 5. In trials, the mRNA vaccine ...

Moderna built an artificial intelligence that reads a patient’s tumor and decides what that patient’s medicine should be.